CompanyDeals

Winner Medical Expands Global Footprint with Acquisition of Global Resources International

Company

AstraZeneca Launches South Korea Innovation Program with Focus on Chinese Market Expansion

CompanyDrug

UCB’s Bimzelx Gains FDA Approval for Three Additional Autoimmune Indications

CompanyDrug

HBOW Bio’s First-in-Class Tumor Imaging Drug NC527-X Receives NMPA Clinical Trial Approval

CompanyDrug

CDE’s BL-B01D1 on Track for Breakthrough Therapy Designations for EGFR Wild-Type and Mutant NSCLC

CompanyMedical Device

Acotec Scientific’s Heart Valve Balloon Dilatation Catheter RunFlow Wins NMPA Approval

CompanyDeals

AimingMed Technologies Partners with RekeyMed to Advance Biotech and Organoid Innovations

CompanyDrug

Shanghai Fudan-Zhangjiang Enrolls First Patient in U.S. Phase II Study for Port Wine Stain Treatment

CompanyDrug

Antengene’s Xpovio Receives NDA Approval in Thailand for Multiple Myeloma Treatment

CompanyDrug

Wuhan YZY Biopharma Presents M701 Interim Results at 2024 ESMO Congress for NSCLC-Related Pleural Effusion

CompanyDrug

Allist Pharmaceuticals’ EGFR Inhibitor AST2303 Approved for Clinical Trial in NSCLC by NMPA

CompanyDrug

Haisco Pharmaceutical’s HSK21542 for Itching in Dialysis Patients Receives NMPA Review